Ann: Quarterly Report - December 2015, page-2

Human health revenue increased from $6.04M in H1 FY2015 to around $6.5M in H1 FY2016 - an increase of 8%. The growth from H1 FY2014 to FY2015 was 19% ($5.07M to $6.04M). Growth has slowed, but is still respectable.  

We’re starting see more product innovation in what is becoming a new area of growth and opportunity for the company -
(1) The nPulse seems to be licensed from a company in the US called NP Medical. MLA appears to have taken the opportunity to market/manufacture this as an OEM customer under their Tuta brand.
http://www.prweb.com/releases/2013/5/prweb10711458.htm
http://www.npmedical.com/products/needle-free-access-devices/npulse

(2) The DualCap seems an innovative product filling an unmet need - particularly the dark blue cap for male luer connectors. Like the nPulse, MLA seems to have reached an arrangement with another company (Catheter Connections) in recent times.
http://dualcap.com
http://dualcap.com/product/ (see video at the bottom which gives details on the dark blue cap)

The impression this report gives is that even with the major distraction of selling Medivet, things on the human side have not been left to stagnate. With IT upgrades going on it looks like they are taking the time now to get their internal platforms on the right footing before any acquisitions down the track (which result in further IT spend of merging data and systems)

The company ends the December quarter with $352K in the bank. Hopefully future 4C reports will show this balance increasing and growing (along with the profits of the company!).